Yahoo Finance

Yttrium Trichloride-90 Y (CAS 39271-65-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

Dublin, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The "Yttrium Trichloride-90 Y (CAS 39271-65-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added ...
Hosted on MSN

China produces Yttrium-90 in commercial nuclear reactor for cancer treatments

China has potentially revolutionized cancer therapy by producing Yttrium-90, a powerful beta-emitting isotope used to target liver tumors, using a commercial heavy-water reactor at the Qinshan Nuclear ...
ascopubs.org

Safety of Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed Low-Grade, Follicular, or Transformed Non-Hodgkin’s Lymphoma

Early Autologous Stem-Cell Transplantation Versus Conventional Chemotherapy as Front-Line Therapy in High-Risk, Aggressive Non-Hodgkin’s Lymphoma: An Italian Multicenter Randomized Trial Results: ...
ascopubs.org

Subsequent Chemotherapy Regimens Are Well Tolerated After Radioimmunotherapy With Yttrium-90 Ibritumomab Tiuxetan for Non-Hodgkin’s Lymphoma

Therapy-Related Myeloid Leukemias Are Observed in Patients With Chronic Lymphocytic Leukemia After Treatment With Fludarabine and Chlorambucil: Results of an Intergroup Study, Cancer and Leukemia ...